Literature DB >> 22322412

Epilepsy surgery utilization: who, when, where, and why?

Samuel Wiebe1, Nathalie Jetté.   

Abstract

PURPOSE OF REVIEW: Using the most recent evidence, we provide an update on epilepsy surgery, focusing on its effectiveness, reasons for underutilization, considerations of candidacy and timing for referral for epilepsy surgery evaluation. RECENT
FINDINGS: The course of illness of epilepsy is being characterized. Well conducted studies describe the patterns of seizure remission and relapse with medical therapy and also in response to epilepsy surgery. Epilepsy surgery is highly effective in selected patients with drug-resistant epilepsy (DRE). The risk-benefit of epilepsy surgery is well known and consistent around the world. However, epilepsy surgery remains underutilized. A randomized controlled trial and Clinical Practice Guidelines (CPGs) supporting epilepsy surgery have had no discernible impact on referral rates for epilepsy surgery evaluation. Criteria and guidelines are being developed for identifying patients who need to be referred for epilepsy surgery evaluation. Quality indicators for epilepsy care now also include the need to consider surgical candidacy every 3 years in DRE. New developments in imaging and neurophysiology promise to help clinicians identify and treat patients more accurately.
SUMMARY: Surgery is effective but underused. Comprehensive interventions to translate evidence to practice in epilepsy surgery are urgently needed.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22322412     DOI: 10.1097/WCO.0b013e328350baa6

Source DB:  PubMed          Journal:  Curr Opin Neurol        ISSN: 1350-7540            Impact factor:   5.710


  14 in total

Review 1.  Surgical management of epilepsy.

Authors:  Nathalie Jette; Aylin Y Reid; Samuel Wiebe
Journal:  CMAJ       Date:  2014-06-09       Impact factor: 8.262

2.  Effects of surgical targeting in laser interstitial thermal therapy for mesial temporal lobe epilepsy: A multicenter study of 234 patients.

Authors:  Chengyuan Wu; Walter J Jermakowicz; Srijata Chakravorti; Iahn Cajigas; Ashwini D Sharan; Jonathan R Jagid; Caio M Matias; Michael R Sperling; Robert Buckley; Andrew Ko; Jeffrey G Ojemann; John W Miller; Brett Youngerman; Sameer A Sheth; Guy M McKhann; Adrian W Laxton; Daniel E Couture; Gautam S Popli; Alexander Smith; Ashesh D Mehta; Allen L Ho; Casey H Halpern; Dario J Englot; Joseph S Neimat; Peter E Konrad; Elliot Neal; Fernando L Vale; Kathryn L Holloway; Ellen L Air; Jason Schwalb; Benoit M Dawant; Pierre-Francois D'Haese
Journal:  Epilepsia       Date:  2019-05-21       Impact factor: 5.864

3.  Epilepsy: Imaging the epileptic brain--time for new standards.

Authors:  Neda Bernasconi; Andrea Bernasconi
Journal:  Nat Rev Neurol       Date:  2014-01-14       Impact factor: 42.937

4.  [18F]DPA-714 PET imaging for the quantitative evaluation of early spatiotemporal changes of neuroinflammation in rat brain following status epilepticus.

Authors:  Ken-Ichi Kaneko; Satsuki Irie; Aya Mawatari; Ami Igesaka; Di Hu; Takayoshi Nakaoka; Emi Hayashinaka; Yasuhiro Wada; Hisashi Doi; Yasuyoshi Watanabe; Yilong Cui
Journal:  Eur J Nucl Med Mol Imaging       Date:  2022-02-14       Impact factor: 10.057

5.  Epilepsy care in ontario: an economic analysis of increasing access to epilepsy surgery.

Authors:  James M Bowen; O Carter Snead; Kiran Chandra; Gord Blackhouse; Ron Goeree
Journal:  Ont Health Technol Assess Ser       Date:  2012-07-01

Review 6.  Pharmacoresistance and the role of surgery in difficult to treat epilepsy.

Authors:  Samuel Wiebe; Nathalie Jette
Journal:  Nat Rev Neurol       Date:  2012-09-11       Impact factor: 42.937

Review 7.  Clinical proton MR spectroscopy in central nervous system disorders.

Authors:  Gülin Oz; Jeffry R Alger; Peter B Barker; Robert Bartha; Alberto Bizzi; Chris Boesch; Patrick J Bolan; Kevin M Brindle; Cristina Cudalbu; Alp Dinçer; Ulrike Dydak; Uzay E Emir; Jens Frahm; Ramón Gilberto González; Stephan Gruber; Rolf Gruetter; Rakesh K Gupta; Arend Heerschap; Anke Henning; Hoby P Hetherington; Franklyn A Howe; Petra S Hüppi; Ralph E Hurd; Kantarci Kantarci; Dennis W J Klomp; Roland Kreis; Marijn J Kruiskamp; Martin O Leach; Alexander P Lin; Peter R Luijten; Malgorzata Marjańska; Andrew A Maudsley; Dieter J Meyerhoff; Carolyn E Mountford; Sarah J Nelson; M Necmettin Pamir; Jullie W Pan; Andrew C Peet; Harish Poptani; Stefan Posse; Petra J W Pouwels; Eva-Maria Ratai; Brian D Ross; Tom W Scheenen; Christian Schuster; Ian C P Smith; Brian J Soher; Ivan Tkáč; Daniel B Vigneron; Risto A Kauppinen
Journal:  Radiology       Date:  2014-03       Impact factor: 11.105

8.  Epileptogenic networks and drug-resistant epilepsy: Present and future perspectives of epilepsy research-Utility for the epileptologist and the epilepsy surgeon.

Authors:  Jyotirmoy Banerjee; Sarat P Chandra; Nilesh Kurwale; Manjari Tripathi
Journal:  Ann Indian Acad Neurol       Date:  2014-03       Impact factor: 1.383

Review 9.  Matrix Metalloproteinase 9 in Epilepsy: The Role of Neuroinflammation in Seizure Development.

Authors:  Elżbieta Bronisz; Iwona Kurkowska-Jastrzębska
Journal:  Mediators Inflamm       Date:  2016-12-26       Impact factor: 4.711

10.  Estimation of brain network ictogenicity predicts outcome from epilepsy surgery.

Authors:  M Goodfellow; C Rummel; E Abela; M P Richardson; K Schindler; J R Terry
Journal:  Sci Rep       Date:  2016-07-07       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.